Literature DB >> 9797167

Angiotensinogen levels and obesity in four black populations. ICSHIB Investigators.

R Cooper1, T Forrester, O Ogunbiyi, J Muffinda.   

Abstract

BACKGROUND: The relationship between circulating levels of angiotensinogen and hypertension in the epidemiologic setting has not been studied much. Recent findings related to the association between hypertension and polymorphisms of the angiotensinogen gene have generated new interest in this potential pathway to hypertension.
OBJECTIVES: To examine environmental factors associated with levels of circulating angiotensinogen as determinants of hypertension in populations of African origin.
METHODS: We recruited 1557 participants from communities in Nigeria (n = 611), Zimbabwe (n = 161), Jamaica (n = 476), and Maywood, Illinois, USA (n = 309).
RESULTS: Mean angiotensinogen levels varied widely across groups (Nigeria 1381 ng/ml angiotensin I generated, Zimbabwe 1638 ng/ml angiotensin I generated, Jamaica 1808 ng/ml angiotensin I generated, and Maywood 2039 ng/ml angiotensin I generated). Average body mass index was highly correlated to angiotensinogen level across the population samples, accounting for 90% of the between-sample variation. At the individual level the correlation between body mass index and angiotensinogen level was substantially smaller, in the range 0.04-0.15, although the association attained statistical significance for all but one of the populations. Women had higher levels of angiotensinogen and mean levels in subjects of both sexes declined in late middle age. Hypertensives also had significantly higher levels of angiotensinogen and we noted correlations to blood pressure for two of the four populations.
CONCLUSION: Obesity, sex and age would all appear to be important modifiers of circulating angiotensinogen levels. The variation in level across populations was substantially larger than that which has been found previously in association with known genetic polymorphisms within populations, suggesting the possibility that environmental effects are more important than had previously been recognized.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9797167     DOI: 10.1097/00004872-199816050-00003

Source DB:  PubMed          Journal:  J Hypertens        ISSN: 0263-6352            Impact factor:   4.844


  27 in total

Review 1.  New developments in mechanisms of obesity-induced hypertension: role of adipose tissue.

Authors:  A M Sharma; S Engeli; T Pischon
Journal:  Curr Hypertens Rep       Date:  2001-04       Impact factor: 5.369

Review 2.  Sympathetic nervous system in obesity-related hypertension: mechanisms and clinical implications.

Authors:  Graziela Z Kalil; William G Haynes
Journal:  Hypertens Res       Date:  2011-11-03       Impact factor: 3.872

3.  Human adipose angiotensinogen gene expression and secretion are stimulated by cyclic AMP via increased DNA cyclic AMP responsive element binding activity.

Authors:  Valérie Serazin; Esther Dos Santos; Mireille Morot; Yves Giudicelli
Journal:  Endocrine       Date:  2004-11       Impact factor: 3.633

4.  Obesity induces neuroinflammation mediated by altered expression of the renin-angiotensin system in mouse forebrain nuclei.

Authors:  Annette D de Kloet; David J Pioquinto; Dan Nguyen; Lei Wang; Justin A Smith; Helmut Hiller; Colin Sumners
Journal:  Physiol Behav       Date:  2014-02-06

Review 5.  The renin angiotensin system and the metabolic syndrome.

Authors:  Annette D de Kloet; Eric G Krause; Stephen C Woods
Journal:  Physiol Behav       Date:  2010-04-08

Review 6.  Neuroimmune communication in hypertension and obesity: a new therapeutic angle?

Authors:  Annette D de Kloet; Eric G Krause; Peng D Shi; Jasenka Zubcevic; Mohan K Raizada; Colin Sumners
Journal:  Pharmacol Ther       Date:  2013-02-28       Impact factor: 12.310

7.  Dietary factors and fibroblast growth factor-23 levels in young adults with African ancestry.

Authors:  Dominique Kosk; Holly Kramer; Amy Luke; Pauline Camacho; Pascal Bovet; Jacob Plange Rhule; Terrence Forrester; Myles Wolf; Chris Sempos; Michal L Melamed; Lara R Dugas; Richard Cooper; Ramon Durazo-Arvizu
Journal:  J Bone Miner Metab       Date:  2016-12-09       Impact factor: 2.626

8.  Angiotensin type 1a receptors in the paraventricular nucleus of the hypothalamus protect against diet-induced obesity.

Authors:  Annette D de Kloet; Dipanwita Pati; Lei Wang; Helmut Hiller; Colin Sumners; Charles J Frazier; Randy J Seeley; James P Herman; Stephen C Woods; Eric G Krause
Journal:  J Neurosci       Date:  2013-03-13       Impact factor: 6.167

9.  The effect of angiotensin-converting enzyme inhibition using captopril on energy balance and glucose homeostasis.

Authors:  Annette D de Kloet; Eric G Krause; Dong-Hoon Kim; Randall R Sakai; Randy J Seeley; Stephen C Woods
Journal:  Endocrinology       Date:  2009-06-04       Impact factor: 4.736

10.  Association between evolutionary history of angiotensinogen haplotypes and plasma levels.

Authors:  Laura Fejerman; Nourdine Bouzekri; Xiaodong Wu; Adebowale Adeyemo; Amy Luke; Xiaofeng Zhu; Ryk Ward; Richard S Cooper
Journal:  Hum Genet       Date:  2004-09       Impact factor: 4.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.